Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Henagliflozin/Metformin ER vs Metformin in New-onset T2DM
NCT06888050Phase 4Recruiting
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Apr 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of henagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Zhejiang Provincial People's Hospital. Started Apr 2025; status: recruiting.
02
Drugs
henagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06888050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06888050.